JSH Co.,Ltd. (TYO:150A)
Japan · Delayed Price · Currency is JPY 724.00
-40.00 (-5.24%)
Aug 19, 2026, 3:30 PM JST
JSH Co.,Ltd. Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 5,116 | 4,740 | 3,967 | 3,482 | 2,968 | 2,330 |
Revenue Growth | 28.97% | 19.49% | 13.93% | 17.33% | 27.36% | - |
Gross Profit Gross Profit Growth | 1,581 | 1,421 | 1,450 | 1,253 | 1,131 | 910.44 |
Operating Income Operating Income Growth | -1.8 | -105.8 | 176.28 | 208.41 | 164.69 | 89.37 |
Net Income Net Income Growth | -47.8 | -120.8 | 144.15 | 145.45 | 187.86 | 60.8 |
Earnings Per Share EPS Growth | -8.44 | -21.33 | 25.22 | 31.27 | 41.25 | 15.33 |
EPS Growth | - | - | -19.35% | -24.19% | 169.12% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Regional Revitalization Project Regional Revitalization Project Growth | 2,509 | 2,086 | 1,612 | 1,057 |
Home Medical Care Business Home Medical Care Business Growth | 1,455 | 1,396 | 1,355 | 1,273 |
Others Others Growth | 5 | - | - | - |
Unallocated Adjustments Unallocated Adjustments Growth | -1.39 | - | - | - |
Total Total Growth | 3,967 | 3,482 | 2,968 | 2,330 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 891 | 884 | 810.82 | 1,197 | 803.47 | 675.61 |
Total Debt Total Debt Growth | 1,033 | 1,333 | 469.96 | 160.3 | 261.91 | 577.77 |
Net Cash (Debt) Net Cash Growth | -142 | -449 | 340.86 | 1,037 | 541.56 | 97.84 |
Net Cash Growth | - | - | -67.12% | 91.40% | 453.51% | - |
Net Cash Per Share Net Cash Per Share Growth | -25.06 | -79.30 | 59.64 | 222.82 | 118.91 | 24.66 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -39 | 137.6 | 299.54 | 224.54 | 145.27 |
Capital Expenditures CapEx Growth | - | -580 | -645.05 | -114.38 | -171.72 | -134.64 |
Free Cash Flow Free Cash Flow Growth | - | -619 | -507.45 | 185.16 | 52.81 | 10.63 |
Free Cash Flow Growth | - | - | - | 250.59% | 396.79% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 30.91% | 29.98% | 36.54% | 35.97% | 38.10% | 39.07% |
Operating Margin | -0.03% | -2.23% | 4.44% | 5.99% | 5.55% | 3.84% |
Pretax Margin | -0.50% | -2.65% | 4.53% | 5.59% | 5.44% | 3.26% |
Profit Margin | -0.93% | -2.55% | 3.63% | 4.18% | 6.33% | 2.61% |
FCF Margin | - | -13.06% | -12.79% | 5.32% | 1.78% | 0.46% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 22.39 | 26.65 | - | - |
P/FCF Ratio | - | - | - | 20.93 | - | - |
PS Ratio | 0.85 | 0.41 | 0.81 | 1.11 | - | - |